Tumor control and immune cell changes in the TME indicate potent cytotoxicity and a dynamic, time-dependent remodeling of the immune phenotype following [225Ac]αMSH-PEG-Cy5-C′ dot treatment compared with vehicle-treated control animals. The gene discussed is STAMBP; the disease is neoplasm.